Bone mineral density in diabetes mellitus patients with and without a Charcot foot

Clinical Physiology and Functional Imaging

Volumn 30, Issue 2, 2010, Pages 130-134

  Christensen, Tomas M ^a   Bülow, Jens ^a   Simonsen, Lene ^a   Holstein, Per E ^a,b   Svendsen, Ole L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

Arthropathy; Bone mineral density; Calcaneus; Osteopenia; Osteoporosis

Indexed keywords

COLLAGEN TYPE 1; OSTEOCALCIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCANEUS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOOT DISEASE; HIP; HUMAN; LUMBAR SPINE; MALE; NEUROPATHIC JOINT DISEASE; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; TOE;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; AMPUTATION; BIOLOGICAL MARKERS; BONE DENSITY; CALCANEUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; GAIT DISORDERS, NEUROLOGIC; HIP; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS; TOES;

EID: 76949094786     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2009.00915.x     Document Type: Article

References (23)

1. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994, 843:1-129.
2. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med 1997, 14:357-363.
3. Bjarnason NH, Christiansen C. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone 2000, 26:561-569.
4. Burston B, McNally DS, Nicholson HD. Determination of a standard site for the measurement of bone mineral density of the human calcaneus. J Anat 1998, Pt 3:449-456.
5. Cundy TF, Edmonds ME, Watkins PJ. Osteopenia and metatarsal fractures in diabetic neuropathy. Diabet Med 1985, 2:461-464.
6. Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care 2000, 23:796-800.
7. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, Landsman AS, Lavery LA, Moore JC, Schuberth JM, Wukich DK, Andersen C, Vanore JV. Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg 2006, 45:S1-S66.
8. Goodship AE, Cunningham JL, Oganov V, Darling J, Miles AW, Owen GW. Bone loss during long term space flight is prevented by the application of a short term impulsive mechanical stimulus. Acta Astronaut 1998, 43:65-75.
9. Hastings MK, Sinacore DR, Fielder FA, Johnson JE. Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy. Phys Ther 2005, 85:249-256.
10. Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br 2004, 86:378-383.
11. Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007, 22:1317-1328.
12. Jirkovska A, Kasalicky P, Boucek P, Hosova J, Skibova J. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabet Med 2001, 18:495-500.
13. Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med 1936, 57:307-312.
14. Langton CM, Langton DK. Comparison of bone mineral density and quantitative ultrasound of the calcaneus: site-matched correlation and discrimination of axial BMD status. Br J Radiol 2000, 73:31-35.
15. Petrova NL, Foster AV, Edmonds ME. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes. Diabet Med 2005, 22:756-761.
16. Prouteau S, Benhamou L, Courteix D. Relationships between serum leptin and bone markers during stable weight, weight reduction and weight regain in male and female judoists. Eur J Endocrinol 2006, 154:389-395.
17. Ravn P, Rix M, Andreassen H, Clemmesen B, Bidstrup M, Gunnes M. High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women. Calcif Tissue Int 1997, 60:255-260.
18. Ravn P, Hosking D, Thompson D, Cizza G, Wasnich RD, McClung M, Yates AJ, Bjarnason NH, Christiansen C. Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study. J Clin Endocrinol Metab 1999, 84:2363-2368.
19. Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL, Greenspan SL. Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 2000, 66:100-103.
20. Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore) 1972, 51:191-210.
21. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporos Int 2007, 18:427-444.
22. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995, 18:34-38.
23. Zerahn B, Borgwardt A, Hojsgard C, Lemser T. Ultrasound and BMD measurements of the os calcis in normal Danish adults. Eur J Exp Musculoskel Res 1995, 4:154-159.